Embryonic stem cell-derived pancreatic endoderm transplant with MCT1-suppressing miR-495 attenuates type II diabetes in mice

Endocrine Journal

Volumn 62, Issue 10, 2015, Pages 907-920

  Liang, Dong ^a   Zhang, Yang ^a   Han, Jing ^a   Wang, Wei ^a   Liu, Yin ^a   Li, Junfeng ^a   Jiang, Xia ^a  

^a TIANJIN FIRST CENTRAL HOSPITAL   (China)

Author keywords

Diabetes refere; Human embryonic stem cells; MCT1; miR 495; Pancreatic endoderm

Indexed keywords

GLUCOSE; INSULIN; MICRORNA; MICRORNA 495; MONOCARBOXYLATE TRANSPORTER 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; COTRANSPORTER; MIRN495 MICRORNA, HUMAN; MONOCARBOXYLATE TRANSPORT PROTEIN 1; MONOCARBOXYLATE TRANSPORTER; RNA; RNA, RECOMBINANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL DIFFERENTIATION; CELL TRANSPLANTATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYONIC STEM CELL; GENE THERAPY; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GLUCOSE METABOLISM; GLYCOGENOLYSIS; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN EMBRYONIC STEM CELL DERIVED PANCREATIC ENDODERM CELL; IMMUNOFLUORESCENCE; LIPID DIET; LIVER WEIGHT; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS CELL; PANCREAS ISLET BETA CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ADVERSE EFFECTS; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL LINE; COMPARATIVE STUDY; CYTOLOGY; DIABETES MELLITUS, TYPE 2; ENDODERM; GENE TRANSFER; GENETICS; HUMAN EMBRYONIC STEM CELL; HYPERGLYCEMIA; HYPERINSULINISM; METABOLISM; MULTIMODALITY CANCER THERAPY; PANCREAS TRANSPLANTATION; PATHOLOGY; PROCEDURES; RANDOMIZATION; SECRETION (PROCESS); TRANSPLANTATION; XENOGRAFT;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; CELL TRANSPLANTATION; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; ENDODERM; GENE TRANSFER TECHNIQUES; HUMAN EMBRYONIC STEM CELLS; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; INSULIN-SECRETING CELLS; MALE; MICE, INBRED C57BL; MICRORNAS; MONOCARBOXYLIC ACID TRANSPORTERS; PANCREAS TRANSPLANTATION; RANDOM ALLOCATION; RNA; SYMPORTERS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84946022760     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ15-0186     Document Type: Article

References (39)

1. WHO Expert Consultation (2004) Appropriate bodymass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157- 163.
2. Barness LA, Opitz JM, Gilbert-Barness E (2007) Obesity: genetic, molecular, and environmental aspects. Am J Med Genet A 143A:3016-3034.
3. Surwit RS, Kuhn CM, Cochrane C, McCubbin JA, Feinglos MN (1988) Diet-induced type II diabetes in C57BL/6J mice. Diabetes 37:1163-1167.
4. Ikemoto S, Takahashi M, Tsunoda N, Maruyama K, Itakura H, et al. (1996) High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils. Metabolism 45:1539-1546.
5. Astrup A, Buemann B, Western P, Toubro S, Raben A, et al. (1994) Obesity as an adaptation to a high-fat diet: evidence from a cross-sectional study. Am J Clin Nutr 59:350-355.
6. Ng SF, Lin RC, Laybutt DR, Barres R, Owens JA, et al. (2010) Chronic high-fat diet in fathers programs beta-cell dysfunction in female rat offspring. Nature 467:963-966.
7. Schuit FC, In’t Veld PA, Pipeleers DG (1988) Glucose stimulates proinsulin biosynthesis by a dose-dependent recruitment of pancreatic beta cells. Proc Natl Acad Sci U S A 85:3865-3869.
8. Abderrahmani A, Plaisance V, Lovis P, Regazzi R (2006) Mechanisms controlling the expression of the components of the exocytotic apparatus under physiological and pathological conditions. Biochem Soc Trans 34:696-700.
9. Pullen TJ, Rutter GA (2013) When less is more: the forbidden fruits of gene repression in the adult beta-cell. Diabetes Obes Metab 15:503-512.
10. Zhao C, Wilson MC, Schuit F, Halestrap AP, Rutter GA (2001) Expression and distribution of lactate/monocarboxylate transporter isoforms in pancreatic islets and the exocrine pancreas. Diabetes 50:361-366.
11. Rutter GA, Pullen TJ, Hodson DJ, Martinez-Sanchez A (2015) Pancreatic beta-cell identity, glucose sensing and the control of insulin secretion. Biochem J 466:203- 218.
12. Ishihara H, Wang H, Drewes LR, Wollheim CB (1999) Overexpression of monocarboxylate transporter and lactate dehydrogenase alters insulin secretory responses to pyruvate and lactate in beta cells. J Clin Invest 104:1621-1629.
13. Pullen TJ, Sylow L, Sun G, Halestrap AP, Richter EA, et al. (2012) Overexpression of monocarboxylate transporter-1 (SLC16A1) in mouse pancreatic betacells leads to relative hyperinsulinism during exercise. Diabetes 61:1719-1725.
14. Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, et al. (2008) Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 26:443-452.
15. Rezania A, Bruin JE, Riedel MJ, Mojibian M, Asadi A, et al. (2012) Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice. Diabetes 61:2016-2029.
16. Pagliuca FW, Millman JR, Gurtler M, Segel M, Van Dervort A, et al. (2014) Generation of Functional Human Pancreatic beta Cells In Vitro. Cell 159:428- 439.
17. Ludwig TE, Bergendahl V, Levenstein ME, Yu J, Probasco MD, et al. (2006) Feeder-independent culture of human embryonic stem cells. Nat Methods 3:637- 646.
18. Ehses JA, Perren A, Eppler E, Ribaux P, Pospisilik JA, et al. (2007) Increased number of islet-associated macrophages in type 2 diabetes. Diabetes 56:2356-2370.
19. Niwa H, Miyazaki J, Smith AG (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24:372- 376.
20. Jensen J (2004) Gene regulatory factors in pancreatic development. Dev Dyn 229:176-200.
21. Jorgensen MC, Ahnfelt-Ronne J, Hald J, Madsen OD, Serup P, et al. (2007) An illustrated review of early pancreas development in the mouse. Endocr Rev 28:685- 705.
22. Zorn AM, Wells JM (2007) Molecular basis of vertebrate endoderm development. Int Rev Cytol 259:49-111.
23. Cawthorne C, Swindell R, Stratford IJ, Dive C, Welman A (2007) Comparison of doxycycline delivery methods for Tet-inducible gene expression in a subcutaneous xenograft model. J Biomol Tech 18:120-123.
24. Finegood DT, Scaglia L, Bonner-Weir S (1995) Dynamics of beta-cell mass in the growing rat pancreas. Estimation with a simple mathematical model. Diabetes 44:249-256.
25. Efrat S (1996) Genetic engineering of B-cells for cell therapy of diabetes: cell growth, function, and immunogenicity. Diabetes Rev 4:224-234.
26. Porat S, Weinberg-Corem N, Tornovsky-Babaey S, Schyr-Ben-Haroush R, Hija A, et al. (2011) Control of pancreatic beta cell regeneration by glucose metabolism. Cell Metab13:440-449.
27. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM (1997) Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A 94:2557-2562.
28. Strable MS, Ntambi JM (2010) Genetic control of de novo lipogenesis: Role in diet-induced obesity. Crit RevBiochem Mol Biol 45:199-214.
29. McDevitt RM, Bott SJ, Harding M, Coward WA, Bluck LJ, et al. (2001) De novo lipogenesis during controlled overfeeding with sucrose or glucose in lean and obese women. Am J Clin Nutr 74:737-746.
30. Adams LA, Angulo P, Lindor KD (2005) Nonalcoholic fatty liver disease. CMAJ 172:899-905.
31. Golay A, Swislocki AL, Chen YD, Reaven GM (1987) Relationships between plasma-free fatty acid concentration, endogenous glucose production, and fasting hyperglycemia in normal and non-insulin-dependent diabetic individuals. Metabolism 36:692-696.
32. Gil-Campos M, Canete R, Gil A (2004) Hormones regulating lipid metabolism and plasma lipids in childhood obesity. Int J Obes Relat Metab Disord 28 Suppl 3:S75-80.
33. Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, et al. (2003) Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 423:550-555.
34. Puigserver P, Spiegelman BM (2003) Peroxisome proliferator- activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev 24:78-90.
35. Duan X, Zhan Q, Song B, Zeng S, Zhou J, et al. (2014) Detection of platelet microRNA expression in patients with diabetes mellitus with or without ischemic stroke. J Diabetes Complications 28:705-710.
36. Liu D, Zhang XL, Yan CH, Li Y, Tian XX, et al. (2015) MicroRNA-495 regulates the proliferation and apoptosis of human umbilical vein endothelial cells by targeting chemokine CCL2. Thromb Res 135:146-154.
37. Chu H, Chen X, Wang H, Du Y, Wang Y, et al. (2014) MiR-495 regulates proliferation and migration in NSCLC by targeting MTA3. Tumour Biol 35:3487- 3494.
38. Song L, Li Y, Li W, Wu S, Li Z (2014) miR-495 enhances the sensitivity of non-small cell lung cancer cells to platinum by modulation of copper-transporting P-type adenosine triphosphatase A (ATP7A). J Cell Biochem 115:1234-1242.
39. Jiang X, Huang H, Li Z, He C, Li Y, et al. (2012) MiR- 495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia. Proc Natl Acad Sci U S A 109:19397-19402